Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedAdvisor Limited ( (AU:MDR) ) has issued an update.
MedAdvisor Limited announced the quotation of 7,084,545 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from September 9, 2025. This move is part of the company’s strategy to enhance its market presence and potentially increase liquidity, reflecting its ongoing efforts to strengthen its financial position and operational capabilities in the digital health sector.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, focusing on providing digital health solutions. The company primarily offers platforms and services that enhance medication management and patient engagement, targeting both consumers and healthcare professionals.
Average Trading Volume: 1,014,720
Technical Sentiment Signal: Sell
Current Market Cap: A$28.76M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.